Medicare Enrolled
Dr. Scott Seals, MD
Hematology & Oncology · Rockwall, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Seals from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Seals? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Seals
Dr. Scott Seals is a hematology & oncology in Rockwall, TX, with 18 years in practice. Based on federal Medicare data, Dr. Seals performed 70,687 Medicare services across 2,618 unique beneficiaries.
Between the years covered by Open Payments, Dr. Seals received a total of $2,278 from 42 pharmaceutical and/or device companies across 130 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Seals is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 13% volume in TX$ $2,278 industry payments
Medicare Practice Summary
Medicare Utilization ↗70,687
Medicare services
Top 13% in TX for hematology & oncology
2,618
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,927 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) | 15,150 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 14,700 | $43 | $137 |
| Iron sucrose injection (Venofer) | 13,600 | $0 | $2 |
| Iron infusion (Feraheme) | 9,690 | $0 | $5 |
| Paclitaxel chemotherapy injection | 6,390 | $0 | $8 |
| Dexamethasone injection (steroid) | 1,752 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,120 | $1 | $114 |
| Complete blood count (CBC) with differential | 944 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 940 | $0 | $24 |
| Blood draw (venipuncture) | 723 | $8 | $20 |
| Comprehensive metabolic blood panel | 687 | $10 | $64 |
| Office visit, established patient (20-29 min) | 682 | $62 | $250 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 461 | $271 | $2,762 |
| Injection, fluorouracil, 500 mg | 367 | $2 | $13 |
| Administration of chemotherapy into vein, 1 hour or less | 285 | $97 | $707 |
| Injection of additional new drug or substance into vein | 253 | $11 | $108 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 252 | $86 | $1,348 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 211 | $22 | $157 |
| Office visit, established patient (30-39 min) | 203 | $95 | $368 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 176 | $177 | $700 |
| Injection, carboplatin, 50 mg | 155 | $2 | $300 |
| Drug injection, under skin or into muscle | 132 | $11 | $96 |
| Immunoglobulin level test | 114 | $9 | $56 |
| Ferritin level test (iron stores) | 109 | $13 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 109 | $47 | $313 |
| Injection, diphenhydramine hcl, up to 50 mg | 107 | $1 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 98 | $48 | $344 |
| Reticulated (young) platelet measurement | 96 | $35 | $143 |
| Iron level test | 90 | $6 | $27 |
| Iron binding capacity test | 90 | $9 | $35 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 86 | $176 | $700 |
| Administration of chemotherapy into vein, each additional hour | 83 | $21 | $161 |
| Measurement of immunoglobulin light chains | 78 | $17 | $60 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $134 | $3,675 |
| Irrigation of implanted venous access drug delivery device | 57 | $16 | $114 |
| Unclassified drugs | 56 | $1 | $8 |
| Microscopic examination for white blood cells with manual cell count | 55 | $4 | $22 |
| Complete blood count (CBC), automated | 55 | $6 | $34 |
| Administration of additional new drug or substance into vein using push technique | 54 | $41 | $289 |
| Infusion, normal saline solution , 1000 cc | 50 | $2 | $19 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 42 | $14 | $100 |
| Drawing of blood for a medical problem | 40 | $68 | $264 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 40 | $121 | $500 |
| Infusion into a vein for hydration, each additional hour | 34 | $10 | $75 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 34 | $25 | $145 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 29 | $1 | $17 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 28 | $1,141 | $4,802 |
| New patient office visit (45-59 min) | 26 | $119 | $565 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 26 | $91 | $657 |
| New patient office visit, complex (60-74 min) | 22 | $160 | $709 |
| Administration of chemotherapy into vein using push technique | 21 | $76 | $500 |
| Lactate dehydrogenase (enzyme) level | 19 | $6 | $31 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.4% high complexity
78.7% medium
6.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,278
Total received (2018-2024)
Avg $325/year across 7 years
Bottom 42% in TX for hematology & oncology
42
Companies
130
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,208 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$69 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$626
2023$590
2022$191
2021$105
2020$72
2019$385
2018$310
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$496
E.R. Squibb & Sons, L.L.C.
$167
PFIZER INC.
$153
GENZYME CORPORATION
$104
Pharmacyclics LLC, An AbbVie Company
$104
Amgen Inc.
$100
Janssen Pharmaceuticals, Inc
$95
ABBVIE INC.
$94
Gilead Sciences, Inc.
$85
Merck Sharp & Dohme Corporation
$72
Incyte Corporation
$66
PharmaEssentia USA Corporation
$60
Ipsen Biopharmaceuticals, Inc
$59
Astellas Pharma US Inc
$48
AstraZeneca Pharmaceuticals LP
$40
Myovant Sciences Inc.
$36
Merck Sharp & Dohme LLC
$35
GlaxoSmithKline, LLC.
$33
Rigel Pharmaceuticals, Inc.
$33
Bayer HealthCare Pharmaceuticals Inc.
$25
CTI BioPharma Corp.
$24
Kite Pharma, Inc.
$24
Sumitomo Pharma America, Inc.
$22
Tempus AI, Inc
$21
Sirtex Medical Inc
$20
Sobi, Inc
$20
TESARO, Inc.
$20
Eisai Inc.
$19
Medtronic USA, Inc.
$18
Lilly USA, LLC
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
Daiichi Sankyo Inc.
$18
GE HealthCare
$17
AbbVie Inc.
$16
Seagen Inc.
$15
Janssen Biotech, Inc.
$15
Kyowa Kirin, Inc.
$15
Acrotech Biopharma LLC
$12
AMAG Pharmaceuticals, Inc.
$11
Celgene Corporation
$11
Lexicon Pharmaceuticals, Inc.
$10
APO-PHARMA USA, INC.
$9
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · BELEODAQ · BESREMI · BOSULIF · CABLIVI · DARZALEX · DOPTELET · ELITEK · EPKINLY · FERAHEME · FERRIPROX · Fabhalta · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · OJJAARA · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · PIQRAY · PLUVICTO · POTELIGEO · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TABRECTA · TASIGNA · Trodelvy · VENCLEXTA · VERZENIO · Vanflyta · Vonjo · XALKORI · XARELTO · XT CDX · XTANDI · Xermelo · Xtandi · YERVOY · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
100
Per 100K population
85.5
County median income
$124,917
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL ROCKWALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Seals is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Seals experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Seals performed 15,150 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Seals receive payments from pharmaceutical companies?
Yes. Dr. Seals received a total of $2,278 from 42 companies across 130 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Seals's costs compare to other hematology & oncologys in Rockwall?
Dr. Seals's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Seals) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Rockwall
Browse hematology & oncologys in Rockwall ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology